These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8429246)

  • 41. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
    Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].
    Shirasaka T; Aiba K; Araki H; Suzuki M; Terashima M; Mikami Y
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):456-66. PubMed ID: 10097742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
    Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ
    Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cisplatin in combination with continuous VP16 infusion as second line chemotherapy in ovarian carcinoma. A pilot study.
    Menczer J; Ben-Baruch G; Rizel S; Brenner H
    Eur J Gynaecol Oncol; 1992; 13(4):316-8. PubMed ID: 1516581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo.
    Kojima M; Kikkawa F; Oguchi H; Mizuno K; Maeda O; Tamakoshi K; Ishikawa H; Kawai M; Suganuma N; Tomoda Y
    Eur J Cancer; 1994; 30A(6):773-8. PubMed ID: 7917536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bisdioxopiperazine, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187), enhances the antiproliferative effect of cisplatin on human ovarian cancer cells.
    Scambia G; Della Bitta R; Benedetti Panici P; De Vincenzo R; Contu G; Ercoli A; Bonanno G; Pierelli L; Mancuso S
    Gynecol Oncol; 1995 Apr; 57(1):16-22. PubMed ID: 7705696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Schedule-dependent combined sensitivity testing of anti-cancer agents in human gastric carcinoma cell lines.
    Murashima N; Gochi A; Kenmotsu M; Hamazaki K; Funaki M; Ohtsuka S; Tanaka N
    J Int Med Res; 2001; 29(3):189-97. PubMed ID: 11471856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sensitivity to etoposide in cultured cells from cervical squamous cell carcinoma].
    Maeda T; Ueda M; Yamada T; Kubo H; Okamura S; Sano T; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2050-6. PubMed ID: 3794454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer.
    Markman M; Hakes T; Reichman B; Curtin J; Barakat R; Rubin S; Jones W; Lewis JL; Almadrones L; Hoskins W
    J Cancer Res Clin Oncol; 1992; 119(1):55-7. PubMed ID: 1400568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell lines.
    Van Moorsel CJ; Smid K; Voorn DA; Bergman AM; Pinedo HM; Peters GJ
    Int J Oncol; 2003 Jan; 22(1):201-7. PubMed ID: 12469205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different interaction of cisplatin and etoposide on in vivo and in vitro tumor systems.
    Soranzo C; Pratesi G; Zunino F
    Anticancer Drugs; 1990 Oct; 1(1):23-8. PubMed ID: 2131031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The inhibitory effect of the combination of antineoplaston A-10 injection with a small dose of cis-diamminedichloroplatinum on cell and tumor growth of human hepatocellular carcinoma.
    Tsuda H; Sugihara S; Nishida H; Hara H; Eriguchi N; Ishii K; Sasaki K; Yoshimura S; Tanaka N
    Jpn J Cancer Res; 1992 May; 83(5):527-31. PubMed ID: 1377669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of cyclic cisplatin and etoposide therapy with continuous UFT administration on the recurrence of endometrial cancer in nude mice.
    Suzuki M; Aida I; Sekiguchi I; Tamada T; Tsuru S
    Oncology; 1993; 50(4):209-13. PubMed ID: 8497371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Blood flow pattern and tumor vascular change following intraperitoneal administration of CDDP in VX2 ovarian tumor].
    Hasegawa E
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):451-6. PubMed ID: 8496635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment.
    Freeburg EM; Goyeneche AA; Telleria CM
    Int J Oncol; 2009 Mar; 34(3):743-55. PubMed ID: 19212679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth.
    Scambia G; Ranelletti FO; Benedetti Panici P; Bonanno G; De Vincenzo R; Piantelli M; Mancuso S
    Anticancer Drugs; 1990 Oct; 1(1):45-8. PubMed ID: 2131036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synchronization effect of cis-dichlorodiammineplatinum on a human neuroblastoma in vitro and in nude mice.
    Yokomori K; Tsuchida Y; Saito S; Yamamoto H; Takakura K; Nomura K
    Gan; 1983 Dec; 74(6):902-10. PubMed ID: 6686824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic etoposide administration: overview of clinical experience.
    Greco FA
    Cancer Treat Rev; 1993; 19 Suppl C():35-45. PubMed ID: 8221715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the exposure dose of etoposide on the cell growth and cell kinetics of human ovarian cancer cells.
    Ohishi Y; Fujiwara K; Kohno I
    Cancer Chemother Pharmacol; 1996; 38(2):141-6. PubMed ID: 8616904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral etoposide is active against platinum-resistant epithelial ovarian cancer.
    Hoskins PJ; Swenerton KD
    J Clin Oncol; 1994 Jan; 12(1):60-3. PubMed ID: 8270985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.